BluePath Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
10,656
+1,902
| +22% | +$211K | 0.57% | 64 |
|
|
2025
Q1 | $981K | Sell |
8,754
-1,100
| -11% | -$123K | 0.57% | 53 |
|
|
2024
Q4 | $886K | Buy |
9,854
+1,299
| +15% | +$117K | 0.48% | 56 |
|
|
2024
Q3 | $717K | Sell |
8,555
-1,745
| -17% | -$146K | 0.44% | 62 |
|
|
2024
Q2 | $707K | Buy |
10,300
+2,960
| +40% | +$203K | 0.5% | 54 |
|
|
2024
Q1 | $538K | Buy |
7,340
+220
| +3% | +$16.1K | 0.41% | 61 |
|
|
2023
Q4 | $602K | Buy |
7,120
+928
| +15% | +$78.4K | 0.51% | 39 |
|
|
2023
Q3 | $464K | Buy |
+6,192
| New | +$464K | 0.43% | 43 |
|